Cutaneous T-Cell Lymphoma (CTCL) Active Not Recruiting Phase 3 Trials for Vorinostat (DB02546)

Also known as: Lymphoma, Cutaneous T-Cell / Cutaneous T-Cell Lymphomas / Cutaneous T-Cell Lymphoma / Cutaneous lymphoma / Lymphoma, T-Cell, Cutaneous

IndicationStatusPhase
DBCOND0071861 (Cutaneous T-Cell Lymphoma (CTCL))Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01728805Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCLTreatment